Analysis of the latest price of capmatinib and price differences in hospitals in different regions

Capmatinib (Capmatinib), as a targeted drug targeting MET exon 14 skipping mutations, has been officially launched in China and has been included in the medical insurance system. This initiative has greatly reduced the financial burden on patients, allowing eligible patients with non-small cell lung cancer to receive treatment through medical insurance reimbursement. However, due to the relatively short time on the market, the supply of medicines in hospitals and pharmacies in some areas is still somewhat tight, and patients may need to consult or make an appointment in advance when purchasing.

The actual selling price of capmatinib may vary in hospitals in different regions of the country. Although the patient's out-of-pocket payment will be unified after medical insurance reimbursement, the retail price of drugs may fluctuate if there is no reimbursement or the inventory of medical institutions in some areas is limited. In some major cities, pharmacies in tertiary hospitals have relatively stable prices due to large purchase volumes, while remote areas or small medical institutions may experience insufficient supply or slightly higher prices.

In overseas markets, the price difference of capmatinib is even more obvious. The price of original medicines is generally high, with a box of medicines usually costing around tens of thousands of yuan, which puts great pressure on patients with average economic conditions. In contrast, overseas generic drugs, such as capmatinib generic drugs produced in Laos, are more affordable, with each box only costing about more than 2,000 yuan. Their drug ingredients are basically the same as the original drugs, but the quality and legality of the drugs need to be ensured through formal channels.

Overall, after capmatinib is launched in China and included in medical insurance, patients can obtain treatment through hospital pharmacies at a more controllable price. At the same time, overseas channels also provide supplementary options, especially the lower prices of generic drugs, providing patients with more flexible medication options. When choosing a drug purchase channel, patients need to consider their own medical insurance situation, drug availability, and doctor's advice to ensure treatment safety and medication continuity.

Reference materials:https://www.drugs.com/